In Vitro Susceptibility of Madurella mycetomatis to Posaconazole and Terbinafine

Alex Belkum, AH Fahal, Wendy Laureijssen - van de Sande

Research output: Contribution to journalArticleAcademicpeer-review

34 Citations (Scopus)


Presently, therapy of eumycetoma in Sudan is still based on surgery combined with prolonged ketoconazole therapy. This usually results in a poor clinical outcome. To determine if posaconazole and terbinafine could offer better therapeutic alternatives, the in vitro susceptibilities of 34 Madurella mycetomatis strains were determined. It appeared that posaconazole was highly active against M. mycetomatis but terbinafine was only moderately active. Since posaconazole has an excellent safety profile, it might provide an important alternative in mycetoma therapy.
Original languageUndefined/Unknown
Pages (from-to)1771-1773
Number of pages3
JournalAntimicrobial Agents & Chemotherapy
Issue number4
Publication statusPublished - 2011

Cite this